Bill Search

  • Introduced
    Feb 19, 2020
  • Passed Senate
  • Passed House
  • Signed into Law
SB 138
Connecticut Senate Bill
AN ACT REQUIRING MANUFACTURERS OF BRAND NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS. To promote competition in the prescription drug market by allowing developers of generic drugs and biosimilar products to obtain reference samples.
Last Action
Senate • Mar 11, 2020: Filed with Legislative Commissioners' Office
Latest bill text

Official Summary/Bill Text

Comments on Bill

Tweets

Do you support this bill?
Yay Nay
Sponsors:
Votes
YES: 12
  • D'Agostino M.
  • Maroney J.
  • Leone C.
  • Gibson B.
  • McCrory D.
  • Fonfara J.
  • Allie-Brennan R.
  • Altobello E.
  • Arconti D.
  • Candelaria J.
  • Luxenberg G.
  • Riley E.
  • D'Agostino M.
  • Maroney J.
  • Leone C.
  • Gibson B.
  • McCrory D.
  • Fonfara J.
  • Allie-Brennan R.
  • Altobello E.
  • Arconti D.
  • Candelaria J.
  • Luxenberg G.
  • Riley E.

NO: 6
  • Witkos K.
  • Cheeseman H.
  • Kissel J.
  • Ackert T.
  • Candelora V.
  • Rutigliano D.
  • Witkos K.
  • Cheeseman H.
  • Kissel J.
  • Ackert T.
  • Candelora V.
  • Rutigliano D.

ABSENT: 1
  • D'Amelio A.

Actions
  • Mar 11, 2020 | Senate
    • Filed with Legislative Commissioners' Office
  • Mar 10, 2020 | Senate
    • Joint Favorable
  • Feb 21, 2020 | Senate
    • Public Hearing 02/27
  • Feb 19, 2020 | Senate
    • Referred to Joint Committee on General Law
Bill Texts